MAM
NVRO

Meeder Asset Management’s NEVRO CORP. NVRO Stock Holding History

Meeder Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,229
Closed -$323K – 2536
2020
Q1 		$323K Buy
3,229
+2,927
+969% +$352K 0.03% 450
2019
Q4 		$35K Buy
+302
New +$29.9K ﹤0.01% 1160

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Meeder Asset Management's NVRO Position: Q2 2020 in Review

Meeder Asset Management sold out of NEVRO CORP. (NVRO) in Q2 2020, closing a stake of 3,229 shares — an estimated $323K sold.

Meeder Asset Management first reported a position in NVRO in Q4 2019 and held it in 2 quarters. The position peaked at $323K in Q1 2020. 202 funds tracked by Wall St. Rank hold NVRO as of Q2 2020.

  • Meeder Asset Management reported no remaining NEVRO CORP. position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 3,229 NEVRO CORP. shares in Q2 2020, an estimated $323K.
  • Meeder Asset Management first reported a position in NEVRO CORP. in Q4 2019 and held it in 2 quarters.
  • Meeder Asset Management's NEVRO CORP. position peaked at $323K in Q1 2020.
  • 202 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.